These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 8532958

  • 1. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases.
    Sofia M, Mormile M, Faraone S, Alifano M, Carratù P, Carratù L.
    Sarcoidosis; 1995 Sep; 12(2):118-23. PubMed ID: 8532958
    [Abstract] [Full Text] [Related]

  • 2. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
    Reichenberger F, Schauer J, Kellner K, Sack U, Stiehl P, Winkler J.
    Lung; 2001 Sep; 179(3):163-74. PubMed ID: 11891606
    [Abstract] [Full Text] [Related]

  • 3. [Changes of the activities of ET-1 in the serum and BALF of ILD patients and their clinical significance].
    Li Z, Xia S, Hou X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jul; 22(7):411-3. PubMed ID: 11775813
    [Abstract] [Full Text] [Related]

  • 4. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].
    Kopiński P, Przybylski G, Jarzemska A, Sładek K, Soja J, Iwaniec T, Balicka-Slusarczyk B, Pinis G, Dyczek A, Szabłowska K, Golińska J, Jankowski M, Szczeklik J.
    Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824
    [Abstract] [Full Text] [Related]

  • 5. Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.
    Terashita K, Kato S, Sata M, Inoue S, Nakamura H, Tomoike H.
    Respirology; 2006 Mar; 11(2):145-51. PubMed ID: 16548898
    [Abstract] [Full Text] [Related]

  • 6. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I.
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [Abstract] [Full Text] [Related]

  • 7. [Level of NCF and TNF-alpha in the BALF of ILD patients and their clinical significance].
    Chen W, Li Z, Hou X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):297-9. PubMed ID: 11326956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
    Günther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Velcovsky HG, Morr H, Grimminger F, Walmrath D, Seeger W.
    Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S, Mukae H, Ishii H, Kakugawa T, Sugiyama K, Sakamoto N, Fujii T, Kadota J, Kohno S.
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
    Meyer KC, Cardoni A, Xiang ZZ.
    J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
    [Abstract] [Full Text] [Related]

  • 16. Chitotriosidase activity in patients with interstitial lung diseases.
    Bargagli E, Margollicci M, Luddi A, Nikiforakis N, Perari MG, Grosso S, Perrone A, Rottoli P.
    Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
    [Abstract] [Full Text] [Related]

  • 17. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of interstitial pulmonary disease activity. I. Protein concentration].
    Zielonka TM, Wałajtys-Rode E, Chazan R, Droszcz W.
    Przegl Lek; 1998 Oct; 55(11):581-5. PubMed ID: 10216371
    [Abstract] [Full Text] [Related]

  • 18. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis.
    Inage M, Nakamura H, Kato S, Saito H, Abe S, Hino T, Tomoike H.
    Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422
    [Abstract] [Full Text] [Related]

  • 19. Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases.
    Fireman E, Shahar I, Shoval S, Messer G, Dvash S, Grief J.
    Lung; 2001 Feb; 179(2):105-17. PubMed ID: 11733853
    [Abstract] [Full Text] [Related]

  • 20. Protein C anticoagulant system in patients with interstitial lung disease.
    Kobayashi H, Gabazza EC, Taguchi O, Wada H, Takeya H, Nishioka J, Yasui H, Kobayashi T, Hataji O, Suzuki K, Adachi Y.
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.